Congress Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $844K | Hold |
3,356
| – | – | 0.01% | 310 |
|
|
2026
Q1 | $730K | Sell |
3,356
-320
| -9% | -$71K | 0.01% | 355 |
|
|
2025
Q4 | $840K | Sell |
3,676
-225
| -6% | -$51.3K | 0.01% | 321 |
|
|
2025
Q3 | $903K | Sell |
3,901
-1,255
| -24% | -$256K | 0.01% | 323 |
|
|
2025
Q2 | $957K | Sell |
5,156
-197
| -4% | -$36.6K | 0.01% | 317 |
|
|
2025
Q1 | $1.12M | Sell |
5,353
-6,975
| -57% | -$1.36M | 0.01% | 302 |
|
|
2024
Q4 | $2.19M | Sell |
12,328
-84,001
| -87% | -$15.4M | 0.01% | 276 |
|
|
2024
Q3 | $19M | Sell |
96,329
-547
| -0.6% | -$102K | 0.13% | 133 |
|
|
2024
Q2 | $16.6M | Buy |
96,876
+137
| +0.1% | +$22.7K | 0.12% | 140 |
|
|
2024
Q1 | $17.6M | Sell |
96,739
-5,500
| -5% | -$948K | 0.13% | 132 |
|
|
2023
Q4 | $15.8M | Sell |
102,239
-4,984
| -5% | -$727K | 0.12% | 135 |
|
|
2023
Q3 | $16M | Buy |
107,223
+2,034
| +2% | +$299K | 0.14% | 128 |
|
|
2023
Q2 | $14.2M | Buy |
105,189
+328
| +0.3% | +$48.1K | 0.12% | 143 |
|
|
2023
Q1 | $16.7M | Sell |
104,861
-140
| -0.1% | -$21.4K | 0.16% | 128 |
|
|
2022
Q4 | $17M | Sell |
105,001
-137
| -0.1% | -$21K | 0.17% | 113 |
|
|
2022
Q3 | $14.1M | Buy |
105,138
+1,311
| +1% | +$188K | 0.15% | 116 |
|
|
2022
Q2 | $15.9M | Buy |
103,827
+475
| +0.5% | +$72.6K | 0.15% | 105 |
|
|
2022
Q1 | $16.8M | Buy |
103,352
+238
| +0.2% | +$34.6K | 0.14% | 105 |
|
|
2021
Q4 | $14M | Buy |
103,114
+1,982
| +2% | +$234K | 0.11% | 130 |
|
|
2021
Q3 | $10.9M | Buy |
101,132
+2,451
| +2% | +$280K | 0.09% | 150 |
|
|
2021
Q2 | $11.1M | Buy |
98,681
+2,461
| +3% | +$277K | 0.09% | 125 |
|
|
2021
Q1 | $10.4M | Buy |
96,220
+2,681
| +3% | +$287K | 0.09% | 124 |
|
|
2020
Q4 | $10M | Buy |
93,539
+5,008
| +6% | +$481K | 0.09% | 122 |
|
|
2020
Q3 | $7.75M | Buy |
88,531
+3,075
| +4% | +$290K | 0.08% | 136 |
|
|
2020
Q2 | $8.39M | Sell |
85,456
-1,002
| -1% | -$88.2K | 0.1% | 110 |
|
|
2020
Q1 | $6.59M | Buy |
86,458
+17,586
| +26% | +$1.5M | 0.1% | 119 |
|
|
2019
Q4 | $6.1M | Sell |
68,872
-5,075
| -7% | -$421K | 0.07% | 153 |
|
|
2019
Q3 | $5.6M | Sell |
73,947
-69,940
| -49% | -$4.8M | 0.07% | 156 |
|
|
2019
Q2 | $10.5M | Buy |
143,887
+3,577
| +3% | +$281K | 0.13% | 92 |
|
|
2019
Q1 | $11.3M | Buy |
140,310
+15,027
| +12% | +$1.23M | 0.15% | 89 |
|
|
2018
Q4 | $11.6M | Sell |
125,283
-13,678
| -10% | -$1.2M | 0.17% | 85 |
|
|
2018
Q3 | $13.1M | Sell |
138,961
-151
| -0.1% | -$14.3K | 0.17% | 86 |
|
|
2018
Q2 | $12.9M | Buy |
139,112
+49,956
| +56% | +$4.88M | 0.18% | 83 |
|
|
2018
Q1 | $8.44M | Sell |
89,156
-275
| -0.3% | -$30.2K | 0.12% | 105 |
|
|
2017
Q4 | $8.65M | Sell |
89,431
-28
| -0% | -$2.64K | 0.13% | 106 |
|
|
2017
Q3 | $7.95M | Buy |
89,459
+82,577
| +1,200% | +$6.29M | 0.12% | 115 |
|
|
2017
Q2 | $499K | Hold |
6,882
| – | – | 0.01% | 225 |
|
|
2017
Q1 | $448K | Sell |
6,882
-135
| -2% | -$8.49K | 0.01% | 226 |
|
|
2016
Q4 | $439K | Hold |
7,017
| – | – | 0.01% | 224 |
|
|
2016
Q3 | $443K | Sell |
7,017
-373
| -5% | -$24.1K | 0.01% | 196 |
|
|
2016
Q2 | $458K | Sell |
7,390
-460
| -6% | -$28K | 0.01% | 198 |
|
|
2016
Q1 | $448K | Hold |
7,850
| – | – | 0.01% | 199 |
|
|
2015
Q4 | $465K | Sell |
7,850
-50
| -0.6% | -$2.88K | 0.01% | 201 |
|
|
2015
Q3 | $430K | Sell |
7,900
-266
| -3% | -$17.3K | 0.01% | 189 |
|
|
2015
Q2 | $549K | Buy |
8,166
+606
| +8% | +$39.6K | 0.02% | 195 |
|
|
2015
Q1 | $443K | Sell |
7,560
-9,450
| -56% | -$571K | 0.01% | 196 |
|
|
2014
Q4 | $1.11M | Buy |
17,010
+18
| +0.1% | +$1.14K | 0.03% | 187 |
|
|
2014
Q3 | $981K | Buy |
16,992
+1,227
| +8% | +$68.1K | 0.03% | 186 |
|
|
2014
Q2 | $890K | Sell |
15,765
-530
| -3% | -$27.8K | 0.02% | 190 |
|
|
2014
Q1 | $838K | Buy |
16,295
+65
| +0.4% | +$3.29K | 0.02% | 192 |
|
|
2013
Q4 | $857K | Sell |
16,230
-2,334
| -13% | -$115K | 0.02% | 185 |
|
|
2013
Q3 | $830K | Sell |
18,564
-389
| -2% | -$17.2K | 0.02% | 183 |
|
|
2013
Q2 | $784K | Buy |
+18,953
| New | +$829K | 0.02% | 179 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Congress Asset Management's ABBV Position: Q2 2026 in Review
Congress Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,356 shares worth $844K. The position accounts for 0.01% of the portfolio, ranked #310.
Congress Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $19M in Q3 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Congress Asset Management held 3,356 shares of AbbVie worth $844K as of Q2 2026.
- Congress Asset Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.01% of Congress Asset Management's portfolio in Q2 2026, its #310 holding.
- Congress Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Congress Asset Management's AbbVie position peaked at $19M in Q3 2024.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.